FDA approved

Seattle Clinical Research Center Recognizes FDA Approval of Elinzanetant (Lynkuet) for Moderate to Severe Hot Flashes Following Clinical Trial Participation

by

Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand name Lynkuet), developed by Bayer, for the treatment of moderate to severe vasomotor symptoms (hot flashes) associated with menopause. SCRC participated in multiple clinical trials evaluating elinzanetant, contributing to the pivotal data that helped support its approval. As a … Read more

Seattle Clinical Research Center Contributes to FDA Approval of New Migraine Treatment

by

Seattle, WA – May 9, 2025 – Seattle Clinical Research Center (SCRC) is proud to share that a new treatment for migraine—Atzumi™ (dihydroergotamine) nasal powder—has been approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults. SCRC was one of the clinical trial sites for the pivotal Phase … Read more

Seattle Clinical Research Center Recognizes FDA Approval of New Non-Hormonal Copper IUD Following Clinical Trial Participation

by

Seattle, WA – March 4, 2025 – Seattle Clinical Research Center is pleased to recognize the recent FDA approval of a new non-hormonal copper intrauterine device (IUD), now officially approved for up to three years of use. As one of the leading clinical trial sites involved in the pivotal Phase 3 study, Seattle Clinical Research Center contributed valuable research data … Read more

WE'VE MOVED!

  • 633 Yesler Way
    Seattle, WA 98104
Click Here for More Information